Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Filings indexed 958 across all filing types
Latest filing 2006-06-05 Director's Dealing
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
Director's Dealing 2006
Director's Dealing
2006-06-05 English
Director's Dealing 2006
Director's Dealing
2006-06-05 English
Director's Dealing 2006
Director's Dealing
2006-06-05 English
COPYTELE, INC. S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock incentive plans. The text includes detailed information about the registration of 15,000,000 shares under the CopyTele, Inc. 2003 Share Incentive Plan, including prospectus details, risk factors, and company background. It is not an annual report, earnings release, or any other financial report but a registration statement related to share issuance under an incentive plan. This type of filing is best classified under Regulatory Filings (RNS) as it does not fit into other specific categories and is a general SEC filing related to securities registration.
2006-03-17 English
COPYTELE, INC. 10-Q
Interim / Quarterly Report
2006-03-10 English
COPYTELE INC.
Annual Report
2006-01-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.